Dashboard
Manage Tickers

DFFNCervoMed Inc


$ 24.38 $ -0.01 (-0.04 %)    

Wednesday, 08-May-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 24.39
$ 23.28
$ 0.00 x 0
$ 0.00 x 0
$ 23.28 - $ 24.85
$ 4.28 - $ 26.38
33,037
na
na
$ 0.91
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

diffusion-pharmaceuticals-stockholders-approve-merger-with-eip-pharma-71-of-stockholders-voted-in-favor-of-the-transaction-announces-1-for-15-reverse-stock-split
Diffusion Pharmaceuticals Stockholders App...
08/15/2023 20:13:06

Approximately 71% of Stockholders Voted in Favor of the Transaction Diffusion Announces 1-for-1.5 Reverse Stock Split Merger ...

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
07/06/2023 16:58:38

  On Thursday, 109 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
05/05/2023 17:54:25

  Friday's session saw 100 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-wednesday
Stocks That Hit 52-Week Lows On Wednesday
04/26/2023 18:37:38

  On Wednesday, 345 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
04/03/2023 17:36:59

  On Monday, 76 companies set new 52-week lows.

eip-pharma-and-diffusion-pharmaceuticals-agree-to-merge-into-a-combined-company-to-focus-on-eip-pharmas-pipeline-of-oral-stress-kinase-inhibitors-including-its-lead-drug-candidate-neflamapimod-for-dementia-with-lewy-bodies
EIP Pharma And Diffusion Pharmaceuticals A...
03/30/2023 11:18:08

Combined company expected to have a cash runway through Phase 2b clinical data and to the end of 2024

diffusion-pharmaceuticals-sends-letter-to-stockholders-highlighting-strength-of-board-leadership-and-positive-progress-in-strategic-review-cautioning-stockholders-regarding-lifescis-history-of-stockholder-value-destruction-and-self-dealing
Diffusion Pharmaceuticals Sends Letter To ...
12/05/2022 11:33:15

Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic ...

lifesci-special-opportunities-responded-to-recent-press-release-issued-by-diffusion-pharmaceuticals
LifeSci Special Opportunities Responded to...
11/17/2022 22:21:53

LifeSci Special Opportunities Master Fund Ltd. ("LifeSci Special Opportunities" or "we"), the holder of 96,976 ...

diffusion-pharmaceuticals-q3-eps-137-up-from-599-yoy
Diffusion Pharmaceuticals Q3 EPS $(1.37) U...
11/14/2022 21:41:17

Diffusion Pharmaceuticals (NASDAQ:DFFN) reported quarterly losses of $(1.37) per share. This is a 77.13 percent increase over l...

diffusion-pharmaceuticals-sees-significant-progress-in-its-strategic-review-process
Diffusion Pharmaceuticals Sees Significant...
11/14/2022 11:33:44

Diffusion in Active Bidding Stage and Encouraged by Response to the Strategic Review Process Diffusion Board of Directors Reje...

diffusion-pharmaceuticals-announces-strategic-review-process-to-evaluate-value-enhancing-alternatives-including-opportunities-to-better-leverage-tsc
Diffusion Pharmaceuticals Announces Strate...
10/25/2022 10:36:39

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) ("Diffusion" or the "Company"), a biopharmaceutical company develo...

benzingas-top-ratings-upgrades-downgrades-for-august-16-2022
Benzinga's Top Ratings Upgrades, Downgrade...
08/16/2022 14:12:12

 

hc-wainwright--co-upgrades-diffusion-pharmaceuticals-to-buy-announces-95-price-target
HC Wainwright & Co. Upgrades Diffusion Pha...
08/16/2022 10:26:12

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Diffusion Pharmaceuticals (NASDAQ:DFFN) from Neutral to Buy ...

diffusion-pharmaceuticals-to-initiate-phase-2-trial-in-patients-with-glioblastoma-multiforme-incorporating-innovative-imaging-methodology-to-evaluate-tumor-oxygenation
Diffusion Pharmaceuticals To Initiate Phas...
07/26/2022 11:37:48

Diffusion aligns with FDA on design of an open-label, dose-escalation, Phase 2 safety and efficacy study of trans sodium croc...

diffusion-pharmaceuticals-announces-effects-in-altitude-trial
Diffusion Pharmaceuticals Announces Effect...
06/23/2022 11:33:32

Positive effects on oxygenation observed with the 2.5 mg/kg dose at the end of the exercise interval   Positive effects on ...

dffn-data-from-altitude-trial-expected-in-june-2022
DFFN: Data from Altitude Trial Expected in...
05/25/2022 12:41:58

By David Bautz, PhD NASDAQ:DFFN READ THE FULL DFFN RESEARCH REPORT

diffusion-pharmaceuticals-q1-eps-222-down-from-006-yoy
Diffusion Pharmaceuticals Q1 EPS $(2.22) D...
05/12/2022 20:32:52

Diffusion Pharmaceuticals (NASDAQ:DFFN) reported quarterly losses of $(2.22) per share. This is a 3600 percent decrease over lo...

diffusion-pharmaceuticals-regains-compliance-with-nasdaq-listing-requirements
Diffusion Pharmaceuticals Regains Complian...
05/04/2022 11:26:04

62-biggest-movers-from-yesterday
62 Biggest Movers From Yesterday
04/28/2022 08:17:36

Gainers Tenon Medical, Inc. (NASDAQ: TNON) rose 350% to clsoe at $22.50 on Wednesday after the company priced its IPO at $5....

5-stocks-halted-in-tuesdays-session
5 Stocks Halted In Tuesday's Session
04/19/2022 21:56:21

A circuit breaker is an automatic, temporary trading halt on specific securities when the underlying stock is experiencing time...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION